Pharmacy

Enselin MF Forte Avanadmet

Home » Prescription Drugs 7 » Enselin MF Forte Avanadmet

Rosiglitazone maleate and metformin HCl tablets contain 2 oral antihyperglycemic drugs used in the management of type II diabets . Rosiglitazone maleate is an oral antidiabetic agent which acts primarily by increasing insulin sensitivity. Rosiglitazone improves glycemic control while reducing circulating insulin levels. EnselinMF Fort is indicated as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus when treatment with dual rosiglitazone and metformin therapy is appropriate. Management of type 2 diabetes mellitus should include diet control. Caloric restriction weight loss and exercise are essential for the proper treatment of the diabetic patient because they help improve insulin sensitivity.

Buy Enselin MF Forte Avanadmet and other Prescription Drugs 7 products online at Medstore.

Buy Online at Medstore - Click Here!

About Enselin MF Forte Avanadmet:

Product Type: Prescription Drugs 7

Enselin MF Forte ( Avanadmet Generic Rosiglitazone & Metformin )

Enselin MF Forte (Avanadmet Generic Rosiglitazone & Metformin)

Avanadmet Generic Rosiglitazone & Metformin

2/1000mg 4 Boxes ( 400 Tabs ) 2/1000mg Box ( 100 Tabs ) 2/1000mg 2 Boxes ( 200 Tabs ) 4/1000mg 200 Tablets 4/1000mg 800(4 x 200) Tablets 4/1000mg 400(2 x 200) Tablets Avanadmet Generic Rosiglitazone & Metformin Enselin MF Forte

View more Prescription Drugs 7

Previous Product  Next Product

Pharmacy: Dozens of patents for name-brand drugs are due to expire within the next 14 months, and generic drugs will replace some of the most popular and widely advertised drugs used today. For millions of people worldwide, this means switching from familiar brands like Lipitor to generic equivalents. How will this affect drug companies, and what will be the impact on people who depend on expensive prescription medication? Here, a brief guide: Which drugs are scheduled to go generic? Some real blockbusters. "In the next two years, six of the 10 top-selling drugs will lose their patents," says Chris Woolston in the Los Angeles Times. Lipitor, the world's best-selling drug, which is used to lower cholesterol, will be available as a generic in November of this year. Another best-seller, the blood thinner Plavix, will lose its patent in May 2012. Other well-known drugs with expiring patents include the arthritis treatment Enbrel, the anti-psychotic Zyprexa, as well as drugs for bipolar disorder, HIV, high cholesterol, and other conditions.